Is a COPD patient protected against SARS-CoV-2 virus?

被引：1
|
作者：
Daubin, C. [1 ]
Justet, A. [2 ]
Vabret, A. [3 ]
Bergot, E. [2 ]
Terzi, N. [4 ]
机构：
[1] CHU Caen, Dept Med Intens Care, F-14000 Caen, France
[2] CHU Caen, Dept Pulmonol & Thorac Oncol, F-14000 Caen, France
[3] CHU Caen, Dept Virol, F-14000 Caen, France
[4] CHU Grenoble Alpes, Dept Med Intens Care, F-38000 Grenoble, France
来源：
INFECTIOUS DISEASES NOW | 2021年 / 51卷 / 01期
关键词：
D O I：
10.1016/j.medmal.2020.09.015
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：98 / 99
页数：3
相关论文
共 50 条
  • [21] Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland
    Lynch, Maureen
    Macori, Guerrino
    Fanning, Seamus
    O'Regan, Edel
    Hunt, Eoin
    O'Callaghan, Dermot
    McCullagh, Brian
    Jennings, Cormac
    Fortune, Anne
    EMERGING INFECTIOUS DISEASES, 2021, 27 (09) : 2499 - 2501
  • [22] Beekeepers who tolerate bee stings are not protected against SARS-CoV-2 infections
    Maennle, Heidrun
    Huebner, Jutta
    Muenstedt, Karsten
    TOXICON, 2020, 187 : 279 - 284
  • [23] Evaluation of Multimerization of Aptamers against SARS-CoV-2 Delta Variant VLP as A Refinement Strategy in The Detection of the SARS-CoV-2 Virus
    Nawi, Siti Farah
    Shukri, Amir Muhaimin Akmal
    Mui, Wang Seok
    Lin, Chia Suet
    Marimuthu, Citartan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [24] Investigation of SARS-CoV-2 IgG Binding Capability to Variants of the SARS-CoV-2 Virus
    Johnson, Lucy
    De Gascun, Cillian F.
    Hassan, Jaythoon
    VIRAL IMMUNOLOGY, 2024, 37 (08) : 404 - 410
  • [25] Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
    Feng, Xuemei
    Wang, Hu
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 6 (07) : 925 - 942
  • [26] Bilateral choroidal effusion following vaccination against SARS-CoV-2 virus
    Arthi, M.
    Dabir, Supriya
    Khatri, Manoj
    Rajan, Mohan
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (12) : 4449 - 4450
  • [27] A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice
    Cao, Kangli
    Wang, Xiang
    Peng, Haoran
    Ding, Longfei
    Wang, Xiangwei
    Hu, Yangyang
    Dong, Lanlan
    Yang, Tianhan
    Hong, Xiujing
    Xing, Man
    Li, Duoduo
    Zhu, Cuisong
    He, Xiangchuan
    Zhao, Chen
    Zhao, Ping
    Zhou, Dongming
    Zhang, Xiaoyan
    Xu, Jianqing
    JOURNAL OF VIROLOGY, 2022, 96 (04)
  • [28] Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus
    Rahbar, Mohammad Reza
    Galeh, Hadi Esmaeili Gouvarchin
    Khalili, Saeed
    Jahangiri, Abolfazl
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (05) : 418 - 421
  • [29] Impfung gegen SARS-CoV-2 bei KrebspatientenVaccination against SARS-CoV-2 in cancer patients
    Marie von Lilienfeld-Toal
    Christina Rieger
    Nicola Giesen
    Bernhard Wörmann
    Der Onkologe, 2021, 27 : 691 - 696
  • [30] SARS-CoV-2 infection and cancer Evidence for and against a role of SARS-CoV-2 in cancer onset
    Stingi, Aureliano
    Cirillo, Luca
    BIOESSAYS, 2021, 43 (08)
12345